Pan-keratin Immunostaining in Human Tumors: A Tissue Microarray Study of 15,940 Tumors.

Despite a tendency towards shortened recurrence free ( Figure 4a ; p = 0.1890) and overall survival ( Figure 4b , p = 0.1234) for pan-keratin negative clear cell renal cell carcinomas, this difference did not reach statistical significance.

also in 111,027 other papers